case_images: PMC10794309_01
case_images: A computed tomography image of a metastatic lymph node (blue arrow), measuring 1.2 cm x 0.8 cm in size, at the left suprasternal space (SSLN).
case_images: fsurg-10-1258259-g001.jpg
case_images: PMC10794309_01_fsurg-10-1258259-g001.jpg
case_images: F1
case_images: However, routine check-up US and CT revealed a suspicious lymph node in the suprasternal space 5 years postoperatively (Figure 1), and FNAC confirmed metastatic PTC.
case_images: Surgical view of the metastatic lymph node, after tattooing (white arrow), at the left suprasternal space (SSLN).
case_images: fsurg-10-1258259-g002.jpg
case_images: PMC10794309_01_fsurg-10-1258259-g002.jpg
case_images: F2
case_images: The patient underwent selective neck dissection (SND), including SSLN and LNSS and levels III-V (Figure 2).
case_images: An ultrasound transverse view of a metastatic hypoechoic nodule, measuring 0.9 cm x 1.2 cm in size, within a lymph node between the right sternocleidomastoid and sternohyoid muscles (LNSS).
case_images: fsurg-10-1258259-g003.jpg
case_images: PMC10794309_01_fsurg-10-1258259-g003.jpg
case_images: F3
case_images: At the 1-year follow-up, 7 years after the initial surgery, a newly developed hypoechoic nodule, measuring 0.9 cm x 1.2 cm in size, was found in an LNSS (Figure 3), and FNAC proved metastatic PTC.
case_images: Surgical view of the metastatic lymph node (white arrow) between the right sternocleidomastoid and sternohyoid muscles (LNSS).
case_images: fsurg-10-1258259-g004.jpg
case_images: PMC10794309_01_fsurg-10-1258259-g004.jpg
case_images: F4
case_images: The patient underwent neck dissection at the right SSLN and LNSS, right CND, and right SND at levels II-V (Figure 4).